Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

VGHCX vs HGHAX overlap: 77% of top holdings shared

Bottom line

How much do VGHCX and HGHAX overlap?

77% of their top holdings overlap by weight. 19 securities appear in both funds' top 25, making up 54.2% of VGHCX's assets and 63.5% of HGHAX's. They are largely the same portfolio — owning both adds little diversification.

Updated Nov 22, 2026

Overlap at a glance

VGHCXHGHAX
Weight overlap (top 25)77%
Shared holdings19
Weight in shared holdings54.2%63.5%
Total positions9780
Expense ratio0.33%1.33%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings VGHCX and HGHAX have in common

Holding% of VGHCX% of HGHAXOverlap
Eli Lilly & Co8.61%12.03%8.61%
Merck & Co Inc5.44%6.00%5.44%
Johnson & Johnson4.83%6.75%4.83%
UnitedHealth Group Inc4.05%4.74%4.05%
Gsk Plc3.00%1.17%1.17%
Edwards Lifesciences Corp2.56%2.48%2.48%
Intuitive Surgical Inc2.52%2.88%2.52%
CVS Health Corp2.52%2.84%2.52%
Cencora Inc2.47%2.46%2.46%
Vertex Pharmaceuticals Inc2.36%2.64%2.36%
AbbVie Inc2.30%4.21%2.30%
Danaher Corp2.18%2.57%2.18%
Regeneron Pharmaceuticals Inc2.14%2.02%2.02%
Elevance Health Inc1.83%3.00%1.83%
HCA Healthcare Inc1.68%1.88%1.68%
Boston Scientific Corp1.53%1.88%1.53%
Agilent Technologies Inc1.49%1.54%1.49%
Biogen Inc1.46%1.36%1.36%
Dexcom Inc1.18%1.01%1.01%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in VGHCX

  1. AstraZeneca PLC — 4.59%
  2. Novartis AG — 1.91%
  3. Argenx SE — 1.68%
  4. Ucb Sa — 1.67%
  5. Galderma Group AG — 1.37%
  6. Roche Holding AG — 1.18%

Only in HGHAX

  1. Abbott Laboratories — 1.82%
  2. Thermo Fisher Scientific Inc — 1.58%
  3. Amgen Inc — 1.39%
  4. Stryker Corp — 1.24%
  5. Medtronic PLC — 1.12%
  6. Centene Corp — 1.10%

Asset mix

Asset typeVGHCXHGHAX
Stocks97.6%98.1%
Repurchase agreements2.2%0.4%
Cash & short-term funds0.1%0.9%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryVGHCXHGHAX
US77.6%89.6%
GB7.6%2.4%
JP4.8%—
CH4.5%0.7%
BE3.4%0.8%
IE—2.2%
NL—1.5%
DK1.4%0.8%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do VGHCX and HGHAX overlap?
About 77% by weight. 19 securities appear in both funds' top 25 holdings; they make up 54.2% of VGHCX's assets and 63.5% of HGHAX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do VGHCX and HGHAX have in common?
The largest shared holdings are Eli Lilly & Co, Merck & Co Inc, Johnson & Johnson, UnitedHealth Group Inc, Intuitive Surgical Inc.
Should I own both VGHCX and HGHAX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, VGHCX or HGHAX?
VGHCX is broader, with 97 positions versus 80 for HGHAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.